Palisade Bio director Mary Ann Gray resigns; board adopts declassified structure

PALISADE BIO, INC.

Director Mary Ann Gray resigned effective March 4, 2024, with no disagreement with company.
Board adopted amended bylaws removing classified board structure; directors will now be elected annually.
Change to annual director elections takes effect at the 2024 annual meeting of shareholders.
Other minor administrative amendments were also made to the bylaws.

item 5.02 item 5.03 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Mary Ann Gray

Director

PALI · PALISADE BIO, INC.

Effective: 2024-03-04
Filed: March 6, 2024, 6:59 PM ET

On March 4, 2024, Mary Ann Gray, Ph.D. informed the board of directors (“Board”) of Palisade Bio, Inc. (the “Company”) that she is resigning as a member of the Board effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Mary Ann Gray resigned as Director at PALISADE BIO, INC..

Action: resigned
Role: Director

Exact text from the filing

On March 4, 2024, Mary Ann Gray, Ph.D. informed the board of directors (“Board”) of Palisade Bio, Inc. (the “Company”) that she is resigning as a member of the Board effective immediately.

View on SEC.gov

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

PALISADE BIO, INC.: Amended and restated bylaws to remove classified board structure and provide for annual election of all directors, effective at 2024 annual meeting (effective 2024-02-29).

Change: bylaw amendment
Effective: 2024-02-29

Exact text from the filing

On February 29, 2024, the Board adopted amended and restated bylaws (the “Amended and Restated Bylaws”) for the purpose of removing the Company’s classified Board structure and to provide for the annual election of all members of the Board.

View on SEC.gov

89 governance changes filed in the last 30 days. Browse all governance changes →

PALISADE BIO, INC. filing history →

Source: SEC EDGAR

accession 0001493152-24-009042

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.